Competition from generics are hurting Zoloft, Norvasc and Lipitor sales. Torcetrapib was supposed to save them – but now the pipeline looks pretty empty.
Generics are killing Pfizer
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Hospice waits on a court order when no family can speak for you
Trusting the lab over the patient is the new medical error
Stop calling it burnout: COVID denial and the wounds ER doctors carry
Signs of depression families miss, and the stigma behind it
Hospitals are replacing bedside ICU doctors with a video screen
Doctors on social media should ask this question first
How to be grateful when you are not a grateful person
